CA1018188A - Dopamine derivatives - Google Patents

Dopamine derivatives

Info

Publication number
CA1018188A
CA1018188A CA168,428A CA168428A CA1018188A CA 1018188 A CA1018188 A CA 1018188A CA 168428 A CA168428 A CA 168428A CA 1018188 A CA1018188 A CA 1018188A
Authority
CA
Canada
Prior art keywords
dopamine derivatives
dopamine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA168,428A
Other languages
English (en)
Other versions
CA168428S (en
Inventor
Jack Mills
Ronald R. Tuttle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA1018188(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of CA1018188A publication Critical patent/CA1018188A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA168,428A 1972-04-12 1973-04-11 Dopamine derivatives Expired CA1018188A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24346672A 1972-04-12 1972-04-12

Publications (1)

Publication Number Publication Date
CA1018188A true CA1018188A (en) 1977-09-27

Family

ID=22918877

Family Applications (1)

Application Number Title Priority Date Filing Date
CA168,428A Expired CA1018188A (en) 1972-04-12 1973-04-11 Dopamine derivatives

Country Status (31)

Country Link
JP (2) JPS5825656B2 (lv)
KR (1) KR790000113B1 (lv)
AR (1) AR203822A1 (lv)
AT (1) AT323719B (lv)
AU (1) AU472734B2 (lv)
BE (1) BE798051A (lv)
BG (1) BG23001A3 (lv)
CA (1) CA1018188A (lv)
CH (2) CH569691A5 (lv)
CS (2) CS190448B2 (lv)
CY (1) CY963A (lv)
DD (1) DD107670B3 (lv)
DE (1) DE2317710C2 (lv)
DK (1) DK142750C (lv)
ES (1) ES413639A1 (lv)
FR (1) FR2182947B1 (lv)
GB (1) GB1392674A (lv)
HK (1) HK50178A (lv)
HU (2) HU167597B (lv)
IE (1) IE37511B1 (lv)
IL (1) IL42016A (lv)
KE (1) KE2870A (lv)
MY (1) MY7800381A (lv)
NL (1) NL174459C (lv)
PH (1) PH11041A (lv)
PL (2) PL90695B1 (lv)
RO (2) RO65105A (lv)
SE (1) SE399064B (lv)
SU (1) SU496719A3 (lv)
YU (2) YU36483B (lv)
ZA (1) ZA732136B (lv)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10611728B2 (en) 2014-01-31 2020-04-07 Cognition Therapeutics, Inc. Isoindoline compositions and methods for treating neurodegenerative disease
US11214540B2 (en) 2017-05-15 2022-01-04 Cognition Therapeutics, Inc. Compositions for treating neurodegenerative diseases

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH585693A5 (lv) * 1974-02-08 1977-03-15 Ciba Geigy Ag
US4342692A (en) * 1980-10-20 1982-08-03 Usv Pharmaceutical Corporation Pyrrolidines
ZA825227B (en) * 1981-07-22 1984-03-28 Syntex Inc Substituted pyrrolidine cardiovascular system regulators antihypertensives
JPS6061523A (ja) * 1983-09-16 1985-04-09 Shionogi & Co Ltd 経口用ドブタミン製剤
IL85438A0 (en) * 1987-02-24 1988-07-31 Lilly Co Eli Improvements in or relating to dobutamine salts
JPH0383364U (lv) * 1989-12-18 1991-08-23
AU658188B2 (en) * 1991-05-20 1995-04-06 Tsumura & Co. Phellodendrine analogs and allergy type IV suppressor containing the same as active ingredient
EP0620208B1 (en) * 1993-04-13 1997-07-09 Duphar International Research B.V Production of dobutamine compounds
DE69404063T2 (de) * 1993-04-13 1998-01-22 Duphar Int Res Herstellung von Dobutamin Verbindungen
PT1546088E (pt) 2002-10-03 2015-03-16 Novaremed Ltd Compostos para utilização no tratamento de doenças auto-imunes, de doenças imuno-alérgicas e de rejeição de órgãos ou tecidos transplantados
US7674829B2 (en) 2004-03-26 2010-03-09 Novaremed Limited Compounds for the treatment of AIDS and other viral diseases
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
JP2013501006A (ja) 2009-07-31 2013-01-10 コグニション セラピューティクス インク． 認知機能低下の阻害剤
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
BR112014004414A2 (pt) * 2011-08-25 2017-03-28 Cognition Therapeutics Inc composições e métodos para tratar doença neurodegenerativa
CN114524734B (zh) * 2021-12-27 2024-04-26 嘉实（湖南）医药科技有限公司 一种盐酸多巴酚丁胺的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2276619A (en) * 1942-03-17 N-phentlaliphatic-dihtoroxyphentnl

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10611728B2 (en) 2014-01-31 2020-04-07 Cognition Therapeutics, Inc. Isoindoline compositions and methods for treating neurodegenerative disease
US11691947B2 (en) 2014-01-31 2023-07-04 Cognition Therapeutics, Inc. Isoindoline compositions and methods for treating neurodegenerative disease
US11214540B2 (en) 2017-05-15 2022-01-04 Cognition Therapeutics, Inc. Compositions for treating neurodegenerative diseases
US11981636B2 (en) 2017-05-15 2024-05-14 Cognition Therapeutics, Inc. Compositions for treating neurodegenerative diseases

Also Published As

Publication number Publication date
YU36483B (en) 1984-02-29
AR203822A1 (es) 1975-10-31
IL42016A (en) 1976-05-31
YU97673A (en) 1982-02-25
IE37511B1 (en) 1977-08-03
BG23001A3 (bg) 1977-05-20
DE2317710C2 (de) 1983-08-04
PL94207B1 (lv) 1977-07-30
ZA732136B (en) 1974-03-27
CH580563A5 (lv) 1976-10-15
HU166213B (lv) 1975-02-28
AU5438573A (en) 1974-10-17
DK142750C (da) 1981-08-17
DD107670B3 (de) 1988-04-06
YU37113B (en) 1984-08-31
NL7305097A (lv) 1973-10-16
DD107670A5 (de) 1974-08-12
JPS5825656B2 (ja) 1983-05-28
FR2182947A1 (lv) 1973-12-14
RO65105A (ro) 1980-01-15
CH569691A5 (lv) 1975-11-28
KR790000113B1 (en) 1979-03-20
JPS58131945A (ja) 1983-08-06
CY963A (en) 1978-12-22
SU496719A3 (ru) 1975-12-25
BE798051A (fr) 1973-10-11
AU472734B2 (en) 1976-06-03
SE399064B (sv) 1978-01-30
PH11041A (en) 1977-10-25
DE2317710A1 (de) 1973-10-18
HU167597B (lv) 1975-11-28
GB1392674A (en) 1975-04-30
HK50178A (en) 1978-09-15
DK142750B (da) 1981-01-12
IL42016A0 (en) 1973-06-29
JPS497237A (lv) 1974-01-22
NL174459C (nl) 1984-06-18
CS190406B2 (en) 1979-05-31
KE2870A (en) 1978-09-01
YU321279A (en) 1983-04-27
FR2182947B1 (lv) 1976-07-02
AT323719B (de) 1975-07-25
NL174459B (nl) 1984-01-16
PL90695B1 (lv) 1977-01-31
JPS6221343B2 (lv) 1987-05-12
RO70892A (ro) 1982-02-26
CS190448B2 (en) 1979-05-31
MY7800381A (en) 1978-12-31
ES413639A1 (es) 1976-01-16

Similar Documents

Publication Publication Date Title
CA1018188A (en) Dopamine derivatives
AU467361B2 (en) Q-aryl-4-substituted piperidinoalkanol derivatives
AU496759B2 (en) New pregnan-21-oic derivatives
CA1019738A (en) Isothiocyanopyridine derivatives
AU470719B2 (en) Oxazinoindole-and thiazinoinindole derivatives
CA976967A (en) Diphenylalkyllactamimide derivatives
CA1020946A (en) 1-phenoxy-3-phenoxyethylamino-2-propanol derivatives
AU470763B2 (en) Pyrano-and thiopyranoindole derivatives
CA1018161A (en) Indan-1-carboxamide derivatives
CA1006514A (en) Beta-aminoketone derivatives
CA978526A (en) Pyrano- and thiopyranoindole derivatives
CA981684A (en) Cyclopenteno-quinolone derivatives
CA910910A (en) Pyrimidinylpyrazole derivatives
CA893701A (en) Triazolobenzodiazepinone derivatives
CA898253A (en) Styryl-naphthalene derivatives
CA899353A (en) 1-hydroxyproline derivatives
CA899886A (en) Oxotremarine derivatives
CA901015A (en) Benzophenonimine derivatives
CA904852A (en) Tetrahydrocyclopropadibenzazepine derivatives
CA904885A (en) 1-amino-3-phenoxy-2-propanol derivatives
CA910311A (en) En-amine derivatives
CA891502A (en) Benhydrylquinuclidinol derivatives
CA912581A (en) Zearalane derivatives
CA916153A (en) Dihydropyrimidopyridazine derivatives
CA917653A (en) N-sulphonamide-succinimide derivatives